|
|
Other links at Articles > Pathology and Lab Medicine |
| 4. |
Biomarkers May Predict Response to B Cell Depletion Therapy in Patients With Lupus
|
|
|
Among patients with active, refractory systemic lupus erythematosus, clinical responses to B cell depletion therapy (BCDT) were shorter in those had an expanded autoantibody profile and elevated B lymphocyte stimulator (BLyS) levels at baseline, researchers from the US and UK report in the July issue of the Annals of the Rheumatic Diseases. Reuters Health Information
|
|
|